{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:42:31Z","timestamp":1784137351633,"version":"3.55.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.537205","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T06:21:50Z","timestamp":1601965310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment"],"prefix":"10.3389","volume":"11","author":[{"given":"Ali","family":"Abbara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tia","family":"Hunjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu N. A.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Comninos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma","family":"Izzi-Engbeaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuong M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey H.","family":"Trew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artsiom","family":"Hramyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan N.","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waljit S.","family":"Dhillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"B1","unstructured":"WORLD REPORT ON DISABILITY2011"},{"key":"B2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/er.2017-00236","article-title":"Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment","volume":"39","author":"Abbara","year":"2018","journal-title":"Endocr Rev"},{"key":"B3","unstructured":"Assisted Reproductive Technology National Report Figures for Slide Presentations2016"},{"key":"B4","unstructured":"DuffyJMN FarquharC Priority Setting Partnership for Infertility2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0070-2153(03)58003-6","article-title":"The regulation of oocyte maturation","volume":"58","author":"Voronina","year":"2003","journal-title":"Curr Top Dev Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3232-6","article-title":"Worldwide survey of IVF practices: Trigger, retrieval and embryo transfer techniques","volume":"290","author":"Tobler","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/580171","article-title":"Pharmaceutical options for triggering of final oocyte maturation in ART","volume":"2014","author":"Castillo","year":"2014","journal-title":"BioMed Res Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046682","article-title":"LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000170","article-title":"Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin","volume":"27","author":"Thomsen","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep246","article-title":"GnRHa to trigger final oocyte maturation: a time to reconsider","volume":"24","author":"Humaidan","year":"2009","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI75730","article-title":"Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization","volume":"124","author":"Jayasena","year":"2014","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2332","article-title":"Efficacy of kisspeptin-54 to trigger Oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) therapy","volume":"100","author":"Abbara","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex253","article-title":"A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial","volume":"32","author":"Abbara","year":"2017","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000083140","article-title":"Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat","volume":"80","author":"Irwig","year":"2004","journal-title":"Neuroendocrinology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev143","article-title":"Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men","volume":"30","author":"Jayasena","year":"2015","journal-title":"Hum Reprod"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13569","article-title":"Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment","volume":"88","author":"Abbara","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00193","article-title":"Follicle size on day of trigger most likely to yield a mature oocyte","volume":"9","author":"Abbara","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.11.069","article-title":"Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles","volume":"88","author":"Shapiro","year":"2007","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"Chen","year":"2012","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-7-77","article-title":"Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report","volume":"7","author":"Haas","year":"2014","journal-title":"J Ovarian Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.10.014","article-title":"Gonadotropin-releasing hormone\u00a0agonist trigger in oocyte\u00a0donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study","volume":"105","author":"Vuong","year":"2016","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00137","article-title":"Determinants of the hCG Concentration in the Early Luteal Phase After Final Maturation of Follicles With Bolus Trigger of Recombinant hCG","volume":"11","author":"Vuong","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez235","article-title":"The early luteal hormonal profile in IVF patients triggered with hCG","volume":"35","author":"Vuong","year":"2020","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2020.05.022","article-title":"Shortcomings of an unphysiological triggering of oocyte maturation using human chorionic gonadotropin","volume-title":"Fertil Steril.","author":"Andersen","year":"2020"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0117","article-title":"Expression of KiSS-1 in rat ovary: Putative local regulator of ovulation","volume":"147","author":"Castellano","year":"2006","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.14202\/vetworld.2017.276-280","article-title":"Effect of kisspeptin on in vitro maturation of sheep oocytes","volume":"10","author":"Byri","year":"2017","journal-title":"Vet World"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1071\/RD11118","article-title":"Paradoxical effects of kisspeptin: It enhances oocyte in vitro maturation but has an adverse impact on hatched blastocysts during in vitro culture","volume":"24","author":"Saadeldin","year":"2012","journal-title":"Reprod Fertil Dev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3598","article-title":"Evidence of GnRH antagonist escape in obese women","volume":"99","author":"Roth","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0912","article-title":"Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels","volume":"176","author":"Bang","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B30","first-page":"1","article-title":"Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation","volume-title":"Hum Reprod","author":"Popovic-Todorovic","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.07.757","article-title":"Dose of human chorionic gonadotropin to trigger final oocyte maturation","volume":"106","author":"Irani","year":"2016","journal-title":"Fertil Steril"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8484","article-title":"Hypothalamic regulation of cyclic ovulation: Evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone","volume":"87","author":"McCartney","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(03)00075-4","article-title":"Reproductive biology and IVF: Ovarian stimulation and luteal phase consequences","volume":"14","author":"Fauser","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00092","article-title":"Daytime variation in serum progesterone during the mid-luteal phase in women undergoing in vitro fertilization treatment","volume":"9","author":"Thomsen","year":"2018","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.537205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T07:11:38Z","timestamp":1669101098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.537205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":34,"alternative-id":["10.3389\/fendo.2020.537205"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.537205","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"article-number":"537205"}}